HCC 37 and HCC 38 carry the same 0.166 weight in V28, so the goal is audit-defensible documentation and the separate manifestation HCCs, not a higher diabetes weight Documentation must explicitly link diabetes to its complications , "Diabetes" plus "neuropathy" is not the same as "diabetic neuropathy" for coding purposes Code all documented complications , Multiple diabetes complication codes can be assigned for a single encounter Do not forget manifestation codes , E11.22 requires an N18.x code
when symptoms do appear, they often include weight changes, rapid heartbeat, and signs of thyrotoxicosis
Glutathione IV drips allow for efficient absorption of the nutrients by the body because they bypass the digestive system, making the nutritional compounds available for use by the body immediately
The rodent findings have not translated clearly to humans in the data we have so far
To be eligible, patients must: Be 18 years or older and not pregnant Have a Body Mass Index (BMI) of 30 kg/m to qualify for any of the medications, or Have a BMI of 27 kg/m with at least one weight-related risk factor (e.g., high blood pressure, type 2 diabetes, high cholesterol) to start Phentermine, Phentermine +Topiramate, Metformin, or compounded Tirzepatide, or Have a BMI of 25 kg/m with at least one weight-related risk factor (e.g
